| Gene symbol | CLDN6 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.3 | dbXrefs | |
| Description | claudin 6 | ||||
| Gene symbol | MSLN | Synonyms | MPF, SMRP | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mesothelin | ||||
| Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mucin 1, cell surface associated | ||||
| GTO ID | GTC0953 |
| Trial ID | ChiCTR2100052760 |
| Disease | Lung Non-Small Cell Carcinoma |
| Altered gene | CLDN6|MUC1|MSLN |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Safety and efficacy of CLDN6/MUC1/MSLN CAR T cells in patients with advanced non-small cell lung cancer |
| Year | 2021 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Nanchang University |
| Cohort 1 | |||||||
|
|||||||